Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||
| Goods sale service render cash | 83.03%10.62B | 113.16%6.79B | 109.89%2.92B | 27.22%8.88B | 0.54%5.8B | -23.78%3.18B | -22.68%1.39B | -51.62%6.98B | -56.73%5.77B | -61.23%4.18B |
| Cash received relating to other operating activities | 3.37%618.79M | 74.75%358.13M | 80.30%165.67M | -42.46%126.15M | -26.13%598.61M | -69.95%204.94M | -78.23%91.89M | -91.31%219.23M | -81.83%810.37M | -80.96%681.98M |
| Cash inflows from operating activities | 75.58%11.24B | 110.83%7.14B | 108.06%3.09B | 25.10%9B | -2.75%6.4B | -30.26%3.39B | -33.23%1.49B | -57.53%7.2B | -63.02%6.58B | -66.16%4.86B |
| Goods services cash paid | 77.50%8.91B | 96.05%5.55B | 95.71%2.48B | 21.53%7.64B | 3.43%5.02B | -8.69%2.83B | -21.87%1.27B | -52.70%6.28B | -62.98%4.85B | -70.64%3.1B |
| Staff behalf paid | 97.95%864.32M | 91.41%549.74M | 24.20%178.76M | -18.14%727.61M | -35.01%436.64M | -39.88%287.2M | -63.70%143.93M | -44.63%888.8M | -46.65%671.86M | -42.67%477.72M |
| All taxes paid | -45.66%54.43M | -47.96%39.61M | 12.32%31.71M | -23.53%43.7M | 311.96%100.16M | 403.03%76.11M | 196.58%28.23M | -8.89%57.14M | -74.62%24.31M | -83.24%15.13M |
| Cash paid relating to other operating activities | -36.90%1.13B | 34.23%990.26M | 40.16%461.95M | -68.74%422.42M | 6.95%1.79B | -51.65%737.73M | -31.88%329.58M | -81.89%1.35B | -72.27%1.67B | -62.64%1.53B |
| Cash outflows from operating activities | 49.15%10.96B | 81.32%7.13B | 78.20%3.15B | 2.90%8.83B | 1.71%7.35B | -23.20%3.93B | -29.58%1.77B | -61.72%8.58B | -64.76%7.22B | -67.11%5.12B |
| Net cash flows from operating activities | 129.96%282.95M | 103.67%19.82M | 78.68%-60.28M | 112.61%174.44M | -47.50%-944.58M | -110.33%-540.76M | 1.28%-282.68M | 74.70%-1.38B | 76.28%-640.38M | 78.55%-257.1M |
| Investing cash flow | ||||||||||
| Net cash received from disposal of fix assets、 intangible assets 、other long-term asset | -93.25%1.56K | ---- | ---- | -98.82%2.23M | -58.38%23.16K | -78.08%10.95K | ---- | -19.30%189.39M | -99.19%55.64K | -99.20%49.94K |
| Net cash received from disposal of subsidiaries and other business units | --1.5M | --1.5M | --1.5M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash inflows from investing activities | 6,371.93%1.5M | 13,579.89%1.5M | --1.5M | -98.82%2.23M | -58.38%23.16K | -78.08%10.95K | ---- | -78.42%189.39M | -99.40%55.64K | -99.42%49.94K |
| Cash paid to acquire fixed assets intangible assets and other long-term assets | 177.86%681.35M | 226.47%373.14M | 2,087.51%181.32M | -12.11%573.17M | -27.05%245.22M | 912.01%114.3M | 534.88%8.29M | -50.73%652.16M | -27.67%336.16M | -97.54%11.29M |
| Cash paid to acquire investments | ---- | ---- | ---- | --19.64M | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash paid relating to other investing activities | ---- | ---- | ---- | -99.66%33.81K | ---- | ---- | ---- | --10.01M | ---- | ---- |
| Cash outflows from investing activities | 177.86%681.35M | 226.47%373.14M | 2,087.51%181.32M | -10.47%592.85M | -27.05%245.22M | 912.01%114.3M | 534.88%8.29M | -50.21%662.17M | -27.67%336.16M | -97.54%11.29M |
| Net cash flows from investing activities | -177.27%-679.85M | -225.19%-371.65M | -2,069.45%-179.82M | -24.92%-590.62M | 27.05%-245.19M | -916.41%-114.28M | -572.46%-8.29M | -4.53%-472.79M | 26.21%-336.1M | 97.50%-11.24M |
| Financing cash flow | ||||||||||
| Cash received from capital contributions | -99.41%8M | -99.54%5M | ---- | -57.70%1.37B | --1.37B | --1.08B | --880M | 1,055.61%3.23B | ---- | ---- |
| -Including: Cash received from capital contributions by minority shareholders of subsidiaries | -96.01%8M | -97.51%5M | ---- | --200.35M | --200.49M | --200.49M | ---- | ---- | ---- | ---- |
| Cash from borrowing | ---- | ---- | ---- | -99.35%5M | -99.18%5M | -90.88%5M | -90.88%5M | -92.80%764.03M | -93.63%611.34M | -99.24%54.8M |
| Cash received relating to other financing activities | --558M | --454M | --230M | -79.75%178M | ---- | ---- | ---- | -68.67%879.15M | -20.87%497.23M | -20.87%497.23M |
| Cash inflows from financing activities | -58.73%566M | -57.71%459M | -74.01%230M | -68.21%1.55B | 23.70%1.37B | 96.64%1.09B | 85.52%885M | -64.41%4.87B | -89.45%1.11B | -93.17%552.03M |
| Borrowing repayment | ---- | ---- | ---- | -94.36%10.8M | -92.09%10M | ---- | ---- | -97.52%191.34M | -98.32%126.43M | -98.18%122.1M |
| Dividend interest payment | 117.04%6.57M | 490.10%6.57M | ---- | -92.87%3.52M | -91.69%3.03M | -91.36%1.11M | -92.16%632.02K | -94.14%49.33M | -94.26%36.4M | -97.92%12.89M |
| -Including:Cash payments for dividends or profit to minority shareholders | ---- | ---- | ---- | -26.97%2.4M | ---- | ---- | ---- | -42.80%3.28M | ---- | ---- |
| Cash payments relating to other financing activities | --313.02M | --134.58M | --83.98M | -68.20%233.89M | ---- | ---- | ---- | -1.67%735.46M | ---- | ---- |
| Cash outflows from financing activities | 2,353.48%319.59M | 12,581.86%141.15M | 13,186.95%83.98M | -74.57%248.2M | -92.00%13.03M | -99.18%1.11M | -95.56%632.02K | -89.50%976.13M | -98.17%162.83M | -98.31%134.99M |
| Net cash flows from financing activities | -81.86%246.41M | -70.69%317.85M | -83.49%146.02M | -66.61%1.3B | 43.62%1.36B | 160.01%1.08B | 91.10%884.37M | -11.32%3.9B | -41.47%945.74M | 413.66%417.04M |
| Net cash flow | ||||||||||
| Exchange rate change effecting cash and cash equivalents | 109.52%2.61M | 100.99%142.49K | 99.44%-118.39K | -16,401.05%-13.97M | -84,160.50%-27.47M | -30,042.81%-14.45M | -6,904.95%-21.27M | -80.31%85.71K | -106.52%-32.61K | -115.22%-47.93K |
| Net increase in cash and cash equivalents | -204.85%-147.88M | -108.15%-33.83M | -116.46%-94.19M | -57.32%870.8M | 558.22%141.04M | 179.10%414.89M | 227.13%572.14M | 233.72%2.04B | 98.00%-30.78M | 109.49%148.65M |
| Add:Begin period cash and cash equivalents | 33.31%3.11B | 37.35%3.2B | 37.35%3.2B | 700.35%2.33B | 700.35%2.33B | 700.35%2.33B | 700.35%2.33B | -83.97%291.32M | -83.97%291.32M | -83.97%291.32M |
| End period cash equivalent | 19.72%2.96B | 15.37%3.17B | 7.04%3.11B | 37.35%3.2B | 849.04%2.47B | 524.24%2.75B | 522.83%2.9B | 700.35%2.33B | -6.23%260.54M | 76.07%439.98M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Beijing Dehao International Accounting Firm (Special General Partnership) | -- | -- | -- | Dahua Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.